COGNITION THERAPEUTICS INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that COGNITION THERAPEUTICS INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($4.93M) | Nov 6, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($6.73M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($6.73M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($8.48M) | May 7, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($8.48M) | Nov 6, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($8.48M) | Aug 7, 2025 |
| Q3 | 2025 | Dec 31, 2024 | ($33.97M) | Nov 6, 2025 |
| Q2 | 2025 | Dec 31, 2024 | ($33.97M) | Aug 7, 2025 |
| Q1 | 2025 | Dec 31, 2024 | ($33.97M) | May 7, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($9.94M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($7.04M) | Aug 7, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($7.04M) | Nov 6, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($9.15M) | Nov 6, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($9.15M) | May 7, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($9.15M) | Aug 7, 2025 |
| Q3 | 2024 | Dec 31, 2023 | ($25.79M) | Nov 13, 2024 |
| Q2 | 2024 | Dec 31, 2023 | ($25.79M) | Aug 8, 2024 |
| Q3 | 2024 | Sep 30, 2023 | ($6.75M) | Nov 13, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($4.73M) | Aug 8, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($4.73M) | Nov 13, 2024 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($6.38M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($13.98M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($13.78M) | May 7, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($14.46M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($14.68M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($14.10M) | May 7, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($14.75M) | Nov 13, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($11.82M) | Aug 8, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($8.97M) | May 7, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($12.63M) | Nov 2, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($12.21M) | Aug 8, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($9.41M) | May 4, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($5.22M) | Nov 14, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($5.98M) | Aug 9, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($5.58M) | May 11, 2022 |
| Q3 | 2021 | Sep 30, 2020 | ($4.46M) | Nov 17, 2021 |